Works matching IS 15246175 AND DT 2024 AND VI 26 AND IP 3


Results: 9
    1
    2

    Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double‐blind, multicenter, therapeutic confirmatory, phase III clinical trial.

    Published in:
    Journal of Clinical Hypertension, 2024, v. 26, n. 3, p. 262, doi. 10.1111/jch.14778
    By:
    • Lee, Chan Joo;
    • Kang, Woong Chol;
    • Ihm, Sang Hyun;
    • Sohn, Il Suk;
    • Woo, Jong Shin;
    • Kim, Jin Won;
    • Hong, Soon Jun;
    • Choi, Jung Hyun;
    • Suh, Jung‐Won;
    • Seo, Jae‐Bin;
    • Doh, Joon‐Hyung;
    • Son, Jung‐Woo;
    • Park, Jae‐Hyeong;
    • Lee, Ju‐Hee;
    • Hong, Young Joon;
    • Heo, Jung Ho;
    • Shin, Jinho;
    • Kang, Seok‐Min
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Issue Information.

    Published in:
    Journal of Clinical Hypertension, 2024, v. 26, n. 3, p. 223, doi. 10.1111/jch.14673
    Publication type:
    Article
    9